Q32 Bio Inc. [QTTB] stock is trading at $43.48, up 10.81%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The QTTB shares have gain 10.10% over the last week, with a monthly amount glided 14.51%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Q32 Bio Inc. [NASDAQ: QTTB] stock has seen the most recent analyst activity on June 17, 2024, when Guggenheim initiated its Buy rating and assigned the stock a price target of $100. Previously, Leerink Partners started tracking the stock with Outperform rating on May 21, 2024, and set its price target to $54. On April 11, 2024, Oppenheimer initiated with a Outperform rating and assigned a price target of $50 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $45 on April 02, 2024. Robert W. Baird downgraded its rating to a Neutral and reduced its price target to $1.50 on July 28, 2023. BTIG Research reiterated a Neutral rating for this stock on February 22, 2022, and downed its price target to $29. In a note dated February 22, 2022, RBC Capital Mkts downgraded an Sector Perform rating on this stock.
Q32 Bio Inc. [QTTB] stock has fluctuated between $8.24 and $42.98 over the past year. Currently, Wall Street analysts expect the stock to reach $48.5 within the next 12 months. Q32 Bio Inc. [NASDAQ: QTTB] shares were valued at $43.48 at the most recent close of the market. An investor can expect a potential return of 11.55% based on the average QTTB price forecast.
Analyzing the QTTB fundamentals
Q32 Bio Inc. [NASDAQ:QTTB] reported sales of 0.00M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 0.8% with Operating Profit Margin at -35.79%, Pretax Profit Margin comes in at -24.78%, and Net Profit Margin reading is -34.98%. To continue investigating profitability, this company’s Return on Assets is posted at -0.52, Equity is 220.41 and Total Capital is -0.62. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.41.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.14 points at the first support level, and at 36.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 45.16, and for the 2nd resistance point, it is at 46.84.
Ratios To Look Out For
For context, Q32 Bio Inc.’s Current Ratio is 6.49. In addition, the Quick Ratio stands at 6.49 and the Cash Ratio stands at 5.68.
Transactions by insiders
Recent insider trading involved TZIANABOS ARTHUR, Director, that happened on Mar 25 ’24 when 265.0 shares were sold., Alloway Paul completed a deal on Mar 25 ’24 to sell 268.0 shares. Meanwhile, Michaud Charles Jr sold 75.0 shares on Mar 25 ’24.
